Patents Assigned to Olfactive Ai, Inc.
  • Compositions and methods for treating endocrine diseases and disorders
    Patent number: 12290550
    Abstract: Disclosed herein are compounds and ligands, and compositions formed therewith, that modulate insulin secretion and suppress appetite by activating ectopic olfactory receptors. Also disclosed herein are methods for using the compositions to treat endocrine diseases, such as type-2 diabetes, and disorders, such as abnormal insulin secretion.
    Type: Grant
    Filed: December 13, 2024
    Date of Patent: May 6, 2025
    Assignee: Olfactive Ai, Inc.
    Inventors: Christopher Hanson, William Harries